These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1533 related articles for article (PubMed ID: 28942145)

  • 41. Therapeutic reduction of lysophospholipids in the digestive tract recapitulates the metabolic benefits of bariatric surgery and promotes diabetes remission.
    Cash JG; Konaniah E; Hegde N; Kuhel DG; Watanabe M; Romick-Rosendale L; Hui DY
    Mol Metab; 2018 Oct; 16():55-64. PubMed ID: 30087032
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Chronic inflammation exacerbates glucose metabolism disorders in C57BL/6J mice fed with high-fat diet.
    Wu Y; Wu T; Wu J; Zhao L; Li Q; Varghese Z; Moorhead JF; Powis SH; Chen Y; Ruan XZ
    J Endocrinol; 2013 Dec; 219(3):195-204. PubMed ID: 24029730
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Targeting the Gut-Kidney Axis in Diarrhea with Kidney-Yang Deficiency Syndrome: The Role of Sishen Pills in Regulating TMAO-Mediated Inflammatory Response.
    Xie S; Fang L; Deng N; Shen J; Tan Z; Peng X
    Med Sci Monit; 2024 Jun; 30():e944185. PubMed ID: 38898640
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Resveratrol Attenuates Trimethylamine-N-Oxide (TMAO)-Induced Atherosclerosis by Regulating TMAO Synthesis and Bile Acid Metabolism via Remodeling of the Gut Microbiota.
    Chen ML; Yi L; Zhang Y; Zhou X; Ran L; Yang J; Zhu JD; Zhang QY; Mi MT
    mBio; 2016 Apr; 7(2):e02210-15. PubMed ID: 27048804
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Impaired renal function and dysbiosis of gut microbiota contribute to increased trimethylamine-N-oxide in chronic kidney disease patients.
    Xu KY; Xia GH; Lu JQ; Chen MX; Zhen X; Wang S; You C; Nie J; Zhou HW; Yin J
    Sci Rep; 2017 May; 7(1):1445. PubMed ID: 28469156
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antibiotics-induced perturbations in gut microbial diversity influence metabolic phenotypes in a murine model of high-fat diet-induced obesity.
    Liu D; Wen B; Zhu K; Luo Y; Li J; Li Y; Lin H; Huang J; Liu Z
    Appl Microbiol Biotechnol; 2019 Jul; 103(13):5269-5283. PubMed ID: 31020379
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Lingguizhugan decoction attenuates diet-induced obesity and hepatosteatosis
    Liu MT; Huang YJ; Zhang TY; Tan LB; Lu XF; Qin J
    World J Gastroenterol; 2019 Jul; 25(27):3590-3606. PubMed ID: 31367159
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Choline Diet and Its Gut Microbe-Derived Metabolite, Trimethylamine N-Oxide, Exacerbate Pressure Overload-Induced Heart Failure.
    Organ CL; Otsuka H; Bhushan S; Wang Z; Bradley J; Trivedi R; Polhemus DJ; Tang WH; Wu Y; Hazen SL; Lefer DJ
    Circ Heart Fail; 2016 Jan; 9(1):e002314. PubMed ID: 26699388
    [TBL] [Abstract][Full Text] [Related]  

  • 49. High-Fat Diet Accelerates Carcinogenesis in a Mouse Model of Barrett's Esophagus via Interleukin 8 and Alterations to the Gut Microbiome.
    Münch NS; Fang HY; Ingermann J; Maurer HC; Anand A; Kellner V; Sahm V; Wiethaler M; Baumeister T; Wein F; Einwächter H; Bolze F; Klingenspor M; Haller D; Kavanagh M; Lysaght J; Friedman R; Dannenberg AJ; Pollak M; Holt PR; Muthupalani S; Fox JG; Whary MT; Lee Y; Ren TY; Elliot R; Fitzgerald R; Steiger K; Schmid RM; Wang TC; Quante M
    Gastroenterology; 2019 Aug; 157(2):492-506.e2. PubMed ID: 30998992
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Gut microbiota-dependent trimethylamine n-oxide pathway contributes to the bidirectional relationship between intestinal inflammation and periodontitis.
    Wang Q; Sun Y; Zhou T; Jiang C; A L; Xu W
    Front Cell Infect Microbiol; 2022; 12():1125463. PubMed ID: 36710972
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Attenuation of Circulating Trimethylamine N-Oxide Prevents the Progression of Cardiac and Renal Dysfunction in a Rat Model of Chronic Cardiorenal Syndrome.
    Zou D; Li Y; Sun G
    Front Pharmacol; 2021; 12():751380. PubMed ID: 34721039
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Protective effect of vitexin against high fat-induced vascular endothelial inflammation through inhibiting trimethylamine
    Li W; Deng Z; Xiao S; Du Q; Zhang M; Song H; Zhao C; Zheng L
    Food Funct; 2024 Jul; 15(13):6988-7002. PubMed ID: 38855818
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Depletion of the gut microbiota differentially affects the impact of whey protein on high-fat diet-induced obesity and intestinal permeability.
    Boscaini S; Cabrera-Rubio R; Golubeva A; Nychyk O; Fülling C; Speakman JR; Cotter PD; Cryan JF; Nilaweera KN
    Physiol Rep; 2021 Jun; 9(11):e14867. PubMed ID: 34057306
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Colonic aberrant crypt formation accompanies an increase of opportunistic pathogenic bacteria in C57BL/6 mice fed a high-fat diet.
    Zeng H; Ishaq SL; Liu Z; Bukowski MR
    J Nutr Biochem; 2018 Apr; 54():18-27. PubMed ID: 29223827
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Role of miR-379 in high-fat diet-induced kidney injury and dysfunction.
    Abdollahi M; Kato M; Lanting L; Wang M; Tunduguru R; Natarajan R
    Am J Physiol Renal Physiol; 2022 Dec; 323(6):F686-F699. PubMed ID: 36227097
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Bardoxolone methyl prevents fat deposition and inflammation in the visceral fat of mice fed a high-fat diet.
    Dinh CH; Szabo A; Camer D; Yu Y; Wang H; Huang XF
    Chem Biol Interact; 2015 Mar; 229():1-8. PubMed ID: 25637688
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of Anthocyanin and Flavanol Compounds on Lipid Metabolism and Adipose Tissue Associated Systemic Inflammation in Diet-Induced Obesity.
    van der Heijden RA; Morrison MC; Sheedfar F; Mulder P; Schreurs M; Hommelberg PP; Hofker MH; Schalkwijk C; Kleemann R; Tietge UJ; Koonen DP; Heeringa P
    Mediators Inflamm; 2016; 2016():2042107. PubMed ID: 27365896
    [TBL] [Abstract][Full Text] [Related]  

  • 58. FMO3 and its metabolite TMAO contribute to the formation of gallstones.
    Chen Y; Weng Z; Liu Q; Shao W; Guo W; Chen C; Jiao L; Wang Q; Lu Q; Sun H; Gu A; Hu H; Jiang Z
    Biochim Biophys Acta Mol Basis Dis; 2019 Oct; 1865(10):2576-2585. PubMed ID: 31251986
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Circulating Gut Microbiota Metabolite Trimethylamine N-Oxide (TMAO) and Changes in Bone Density in Response to Weight Loss Diets: The POUNDS Lost Trial.
    Zhou T; Heianza Y; Chen Y; Li X; Sun D; DiDonato JA; Pei X; LeBoff MS; Bray GA; Sacks FM; Qi L
    Diabetes Care; 2019 Aug; 42(8):1365-1371. PubMed ID: 31332027
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Gut Microbiota-Dependent Trimethylamine N-Oxide Associates With Inflammation in Common Variable Immunodeficiency.
    Macpherson ME; Hov JR; Ueland T; Dahl TB; Kummen M; Otterdal K; Holm K; Berge RK; Mollnes TE; Trøseid M; Halvorsen B; Aukrust P; Fevang B; Jørgensen SF
    Front Immunol; 2020; 11():574500. PubMed ID: 33042155
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 77.